300871 回盛生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-1.0871.1003.3368.86417.088
总资产报酬率 ROA (%)-0.5500.5631.8395.91312.501
投入资产回报率 ROIC (%)-0.6330.6602.0906.51014.287

边际利润分析
销售毛利率 (%)22.66620.91622.03227.17537.027
营业利润率 (%)-10.3901.4795.78315.16022.704
息税前利润/营业总收入 (%)-5.6883.6156.92214.70122.144
净利润/营业总收入 (%)-7.9331.6465.15313.33719.314

收益指标分析
经营活动净收益/利润总额(%)58.04027.630105.46988.99597.729
价值变动净收益/利润总额(%)68.446203.95212.3612.9200.482
营业外收支净额/利润总额(%)0.273-21.231-4.316-0.130-0.275

偿债能力分析
流动比率 (X)1.6021.6211.6793.1773.476
速动比率 (X)1.2531.3281.4322.7173.100
资产负债率 (%)49.57049.27648.43240.9540.213
带息债务/全部投入资本 (%)39.91837.23236.72333.24111.071
股东权益/带息债务 (%)143.151159.755164.582195.408783.689
股东权益/负债合计 (%)101.733102.940106.476144.179369.670
利息保障倍数 (X)-1.2031.5095.022-33.417-44.427

营运能力分析
应收账款周转天数 (天)139.094115.881100.27678.32969.415
存货周转天数 (天)142.82795.45697.17489.02573.415